 inhibitory activity culture supernatants alveolar macrophages patients interstitial lung diseases normal conditions release interleukin inhibitors role tissue homeostasis increase activity decrease inhibitory activity IHA supernatants alveolar macrophages healthy long-term smokers healthy nonsmokers study alteration release IHA alveolar macrophages patients interstitial lung diseases sarcoidosis idiopathic pulmonary fibrosis IPF activity alveolar macrophages lipopolysaccharide patients active sarcoidosis mean SD U/ml U/ml healthy non-current smokers HNS IHA alveolar macrophages different groups decrease IHA patients active sarcoidosis percent HNS IPF Prednisolone culture medium physiologic concentrations release release IHA IHA thymocyte proliferation human fibroblast proliferation presence